KRN383

KRN383 Chemische Eigenschaften,Einsatz,Produktion Methoden

• Beschreibung

  KRN383 also inhibited the proliferation of the ITD-positive cell lines with IC(50) values of < or =2.9 nM. A single oral administration of 80 mg/kg of KRN383 eradicated ITD-positive xenograft tumors in nude mice and prolonged the survival of SCID mice carrying ITD-positive AML cells. The effectiveness of a single oral dose of KRN383 suggests that it has the potential to be used in a wide variety of clinical regimens, including multicycle and combination therapies.

KRN383 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(1)Suppliers